New Delhi: The Ministry of Health of the Russian Federation has registered the nasal version of Sputnik V, the world’s first nasal vaccine against Covid-19.
“BREAKING: Russian Ministry of Health registers nasal version of Sputnik V, the world’s first nasal vaccine against COVID-19,” Sputnik V tweeted late Friday.
BREAKING NEWS: Russia’s Health Ministry registers nasal version of Sputnik V, the world’s first nasal vaccine against COVID-19 pic.twitter.com/3rlZhD5yOV
— Sputnik V (@sputnikvaccine) April 1, 2022
Quoting Alexander Gintsburg, director general of the Gamaleya Research Institute of Epidemiology and Microbiology, Russian news agency TASS reported in January that the nasal SARS-CoV-2 vaccine will be in civilian circulation and available to people. Russians within three to four months.
The Gamaleya Research Institute for Epidemiology and Microbiology is a Russian medical research institute within the Russian Ministry of Health, and is best known internationally for developing the first vaccine against SARS-CoV- 2, Sputnik V. This is the world’s first recorded Covid-19. , a vaccine with more than 91.6% efficacy, and is authorized in 71 countries.
“The nasal vaccine for civilian circulation will be available in three to four months,” Gintsburg said in a TASS report.
He also stated that Sputnik V will be effective against the Omicron variant.
“Lab tests show that Sputnik V protects against Omicron in its regular injection form, and it will certainly be effective in its nasal form,” Gintsburg said.
In October 2021, the Ministry of Health of the Russian Federation issued permission to the Gamaleya Research Institute of Epidemiology and Microbiology for the second phase of clinical trials of Sputnik V in the form of a nasal spray.
In May 2021, Sputnik V was first administered in India.
On May 1, the first shipment of 1.50 lakh dozes of the vaccine arrived in India. The Russian Direct Investment Fund (RDIF), in collaboration with Dr. Reddy’s laboratories, delivered the Sputnik V vaccines to India.
Arindam Bagchi, official spokesman for the Union External Affairs Ministry, had said that the Sputnik v vaccine, which arrived in Hyderabad from Russia, would be added to the country’s vaccine arsenal to end the pandemic. . He said this third option will increase India’s vaccination capacity and speed up the country’s vaccination campaign.
The other two options in India at that time were Covishield and Covaxin.
Sputnik V is the world’s first registered vaccine on a well-studied human adenovirus vector platform and is named after the first Soviet space satellite. Adenoviral vectors are modified viruses designed to carry a SARS-CoV-2 gene into the body of the person injected with the vaccine, for cells to read it and make coronavirus spike proteins.
The idea is to trick the body into believing it has been infected, and the self-made spike proteins would train the body to detect and terminate any true SARS-CoV-2 infection before the virus does. havoc. Adenovirus vectors are a recombinant of adenovirus, which is a medium-sized non-enveloped DNA virus that replicates in two phases.
According to the official Sputnik V website, the vaccine was the first coronavirus vaccine to use a heterogeneous booster approach based on two different vectors for two vaccine injections.
Sputnik V demonstrates high virus-neutralizing activity against the Omicron variant and should protect against severe cases and hospitalizations, according to a preliminary laboratory study conducted by the Gamaleya Center.
Find out below Health Tools-
Calculate your body mass index (BMI)
Calculate age calculator through age